01. Doctor Overview

Doctor Overview

Dr. Alberto A. Chiappori specializes in medical oncology and serves at H. Lee Moffitt Cancer Center & Research Institute. There, he is Senior Member of Oncology and Medicine for the Thoracic Oncology Program. Dr. Chiappori specializes in the treatment of thymoma, lung cancer and mesothelioma.

Dr. Chiappori’s medical career began after receiving his board certification in medical oncology in 1997. After graduating from medical school in Lima, Peru, he completed a residency in Illinois and a fellowship in Nashville, Tennessee. Dr. Chiappori joined the Thoracic Oncology Program at Moffitt in 2001, where he is still building his experience.

Dr. Chiappori’s experience and knowledge is prevalent throughout several publications as he continues to not only treat patients, but to expand his clinical research, particularly in the field of lung cancers.

02. Fast Facts

Doctor Fast Facts

Main Specialty: Thoracic Oncology

Other Interests & Specialties: Thymoma, lung cancers and mesothelioma.

Certifications, Awards & Accolades: American Society of Clinical Oncology member, International Association for the Study of Lung Cancer (IASLC) member

Education & Experience:

  • Medical Degree from Cayetano Heredia University of Peru
  • Residency at Southern Illinois University School of Medicine
  • Fellowship in Hematology/Oncology at Vanderbilt University School of Medicine
03. Publications


Molecular Origins of Lung Cancer: Prospects for Personalized Prevention and Therapy. Journal of Thoracic Oncology. October 2011;118(9):2525-2531. doi: 10.1002/cncr.26522

Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic StudyClinical Cancer Research. August 2006;12(15). doi: 10.1158/1078-0432.CCR-05-2379

Phase 1 pharmacokinetic and drug‐interaction study of dasatinib in patients with advanced solid tumorsCancer. January 2010;116(6):1582-1591. doi: 10.1002/cncr.24927

Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumorsCancer. April 2007;109(7):1413-1419. doi: 10.1002/cncr.22522

Photo of Dr. Alberto A. Chiappori

Get Help Contacting Dr. Alberto A. Chiappori

    Privacy policy: All information is secure and will never be released